广告
加载中

中华人寿3亿增资落地 保费连降三年 盈利拐点何时到来?

邢莉 2026-07-21 13:37
邢莉 2026/07/21 13:37

邦小白快读

EN
全文速览

本文核心内容是国有控股寿险公司中华人寿多次增资补血仍未扭转经营颓势,核心重点干货信息如下

1. 中华人寿是国内唯一以“中华”冠名的国有控股寿险公司,成立11年,此次3亿增资后注册资本增至44亿元,截至2025年末总资产419.24亿元,仅在5个省级行政区开设10家分支机构

2. 经营数据层面,中华人寿成立以来累计亏损超过21亿元,保费收入已经连续三年下滑,2026年一季度再次亏损0.45亿元,综合、核心偿付能力仅满足监管达标底线,远低于人身险行业平均水平

3. 当前公司存在终身寿险退保金高增、部分投资资产违约、个险等多元渠道发展不成熟等问题,后续能否推进改革实现盈利拐点仍待观察

本文围绕中华人寿经营现状展开,对保险行业品牌商有以下干货参考内容

1. 产品与消费趋势层面,寿险产品中终身寿险长期退保风险较高,中华人寿两款银保渠道终身寿险最高退保率达到8.4%,品牌商开发产品时需要充分评估长期退保风险,合理设计产品规则与定价

2. 资本运营层面,品牌商可依托母公司股东资源,通过股权增资、发行资本补充债等多元渠道补充资本金,守住监管合规底线,为业务调整争取窗口期

3. 渠道建设层面,单一依赖银保渠道抗风险能力较弱,中华人寿推进渠道多元化后,中介渠道已经超越银保成为第一大保费来源,品牌商可参考该路径布局多元代理渠道,优化渠道结构

本文披露了中小寿险机构的经营现状,对保险从业相关卖家有以下干货参考内容

1. 合规层面,当前寿险行业偿付能力监管底线为综合偿付能力100%、核心偿付能力50%、风险综合评级B类,行业平均偿付能力远高于监管底线,从业者需要时刻监控自身资本充足率,满足合规要求

2. 风险提示:新设寿险机构虽有“七亏八盈”的行业规律,但如果业务结构不合理,即使走完周期也难以实现盈利,需要提前调整业务结构,培育自我造血能力

3. 机会提示:当前中介经纪渠道保费增长较快,中小保险从业者可通过与头部经纪代理机构合作拓展规模,对冲银保渠道下滑的影响

4. 风险提示:投资端需要警惕房地产相关非标资产的信用风险,提前计提减值,加快风险处置

本文以中华人寿为例展现了企业转型调整阶段的经营逻辑,对制造类工厂有以下干货启示

1. 资本运营层面,企业在发展投入期要提前做好资本储备,通过多元渠道补充资本金,应对持续投入带来的资金消耗,避免触碰合规经营红线

2. 渠道布局层面,单一核心渠道抗风险能力较弱,工厂布局销售渠道时要推进多元化布局,在稳定传统合作渠道的同时,积极发展新兴渠道、第三方中介渠道,分散经营风险

3. 投资风险管理层面,企业对外投资要警惕高风险领域资产,本文中华人寿有5.76亿元房地产相关投资资产出现违约,给工厂对外投资敲响警钟,需要提前做好风险评估与减值计提,加快不良资产处置

4. 转型层面,企业进入调整期要及时优化业务结构,培育新的盈利增长点,才能从根本上解决持续亏损的问题

本文梳理了当前中小寿险公司的经营现状,给保险相关服务商带来以下干货内容

1. 行业发展趋势:当前寿险行业分化加剧,中小寿险公司普遍面临资本持续消耗、偿付能力逼近红线的压力,盈利周期大幅拉长,多数机构都处于转型调整阶段,对外服务需求旺盛

2. 客户核心痛点:一是资本补充渠道单一,多数中小寿险公司难以引入外部资本,仅能依赖原有股东持续增资,资本补充压力长期存在;二是渠道建设不完善,个险渠道培育周期长、发展不成熟,需要第三方机构对接渠道资源;三是投资端风险管理能力不足,缺乏不良资产处置的专业能力

3. 业务机会方向:服务商可针对上述痛点,推出资本对接引入、渠道合作对接、投资资产风险处置等针对性服务,挖掘市场增量

本文披露了寿险行业渠道变化的最新情况,对保险相关平台商有以下干货内容

1. 市场需求情况:当前中小寿险公司对多元化销售渠道的需求十分强烈,传统银保渠道保费占比持续下滑,越来越多中小寿险公司需要和中介代理平台开展合作,拓展保费规模

2. 招商运营机会:目前中华人寿已经和84家中介代理机构开展合作,中介渠道已经超越银保成为其第一大保费来源,后续还会有更多中小保险公司加大和中介平台的合作,平台商可针对性开展招商,拓展客户群体

3. 风险规避提示:平台商和寿险机构合作时,需要提前核查合作方的偿付能力与经营合规情况,优先选择资本充足、经营稳定的机构合作;同时要关注合作销售产品的退保风险,提前做好风险预案,避免对平台声誉造成负面影响

本文为寿险行业中小机构发展研究提供了鲜活案例,干货研究内容如下

1. 产业新动向:当前寿险行业分化趋势明显,中小机构面临较大的经营压力,资本补充成为中小机构维持合规运营的核心需求,当前多数中小寿险机构的资本补充仅依赖原有股东增资,外部资本入场意愿较低,资本补充渠道单一

2. 产业新问题:本文案例打破了寿险行业“七亏八盈”的传统规律,部分中小寿险公司成立超过十年,依然面临持续亏损、保费连续下滑的困境,同时叠加退保率高企、投资资产质量不佳、渠道建设不完善等多重问题

3. 研究启示:监管层面可针对中小寿险公司的资本补充需求出台更多支持政策,鼓励多元化资本进入;行业层面需要引导中小机构优化业务结构,培育自身核心盈利能力,避免持续依赖股东资本补血;商业模式层面,中小寿险机构依托股东资源走差异化渠道路线,是当前可行的转型方向

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article focuses on China Life Insurance Co., Ltd. (Zhonghua Renshou), a state-controlled life insurer that has failed to reverse its underperformance despite multiple capital injections. Key takeaways are as follows:

1. Zhonghua Life is the only state-controlled life insurer branded with "China" (Zhonghua) in China. Founded 11 years ago, its registered capital has increased to 4.4 billion yuan after this latest 300 million yuan capital increase. As of the end of 2025, it holds total assets of 41.924 billion yuan, and operates only 10 branches across 5 provincial-level administrative regions.

2. Since its establishment, the company has accumulated net losses exceeding 2.1 billion yuan. Its premium income has declined for three consecutive years, and it posted an additional loss of 45 million yuan in Q1 2026. Both its overall and core solvency ratios only meet the minimum regulatory requirements, far below the industry average for life insurers.

3. The company currently faces multiple challenges: surging surrender volumes for its whole life insurance products, defaults on some investment assets, and underdeveloped distribution channels including the individual agent channel. Whether it can implement reforms to reach a profitability inflection point remains to be seen.

This article analyzes the current operating status of Zhonghua Life, with the following key takeaways for brand players in the insurance industry:

1. Product and consumer trends: Whole life insurance carries high long-term surrender risk. For two of Zhonghua Life's whole life insurance products distributed through the bancassurance channel, the maximum surrender rate reached 8.4%. Insurance brands need to fully assess long-term surrender risk and design product rules and pricing reasonably when developing new offerings.

2. Capital management: Brands can leverage resources from their parent shareholders to replenish capital through multiple channels, including equity injections and capital supplementary bond issuances, to maintain regulatory compliance and buy time for business adjustment.

3. Channel development: Over-reliance on the single bancassurance channel results in weak risk resilience. After Zhonghua Life pushed for channel diversification, the brokerage channel surpassed bancassurance to become its largest source of premium income. Brands can follow this path to build a diversified agency network and optimize channel structure.

This article discloses the current operating conditions of small and medium-sized life insurance institutions, with key insights for insurance sellers and practitioners:

1. Compliance: The current regulatory minimum requirements for life insurer solvency are 100% for overall solvency, 50% for core solvency, and a Category B risk rating. The industry average solvency is far higher than the regulatory floor, so practitioners must constantly monitor their capital adequacy to meet compliance requirements.

2. Risk warning: While the industry adage holds that new life insurers "turn profitable after seven to eight years of operation", unreasonable business structure can prevent profitability even after that cycle. Practitioners need to adjust business structure early and build independent self-sustaining profitability.

3. Opportunity: The brokerage channel is currently seeing rapid premium growth. Small and medium-sized insurance practitioners can expand scale by partnering with leading brokerage and agency institutions to offset the decline of the bancassurance channel.

4. Risk warning: On the investment side, practitioners need to be alert to credit risk in non-standard real estate-related assets, make provision for impairment in advance, and accelerate risk disposal.

This article uses Zhonghua Life as a case study to illustrate operating logic during corporate transformation and adjustment, with the following insights for manufacturing factories:

1. Capital management: Companies in the investment-driven growth stage need to build capital reserves in advance, and replenish capital through multiple channels to offset cash consumption from sustained investment, and avoid crossing regulatory compliance red lines.

2. Channel layout: A single core channel brings weak risk resilience. When building sales channels, factories should pursue diversification: while stabilizing traditional partnership channels, they need to actively develop emerging channels and third-party intermediary channels to spread operating risk.

3. Investment risk management: Companies need to guard against assets in high-risk sectors when making external investments. In this case, 576 million yuan of Zhonghua Life's real estate-related investment assets have defaulted, a warning for manufacturing firms. They need to complete risk assessment and impairment provision in advance, and accelerate the disposal of non-performing assets.

4. Transformation: Companies entering an adjustment period need to optimize business structure in a timely manner and cultivate new profit growth points to fundamentally resolve sustained losses.

This article sorts out the current operating conditions of small and medium-sized life insurers, with the following key insights for insurance-related service providers:

1. Industry development trends: The life insurance industry is seeing growing divergence. Small and medium-sized life insurers generally face pressure from sustained capital consumption and solvency approaching regulatory limits, their profitability cycles have extended significantly, and most are in the transformation and adjustment stage, creating strong demand for external services.

2. Core client pain points: First, most small and medium-sized life insurers have limited capital replenishment channels, and struggle to attract new external capital, relying only on repeated capital injections from existing shareholders, resulting in long-term capital pressure. Second, their channel development is incomplete: the individual agent channel has a long cultivation cycle and remains underdeveloped, so they need third-party institutions to connect to channel resources. Third, they lack professional capacity for investment-side risk management and non-performing asset disposal.

3. Business opportunity directions: Service providers can develop targeted solutions to address these pain points, including capital introduction matching, channel cooperation matching, and investment asset risk disposal services, to tap into new market growth.

This article discloses the latest channel shift in the life insurance industry, with key insights for insurance-related platform operators:

1. Market demand: Small and medium-sized life insurers currently have strong demand for diversified sales channels. The premium share of the traditional bancassurance channel continues to decline, and a growing number of small and medium-sized insurers are seeking partnerships with agency brokerage platforms to expand premium scale.

2. Business development opportunities: Zhonghua Life already partners with 84 agency and brokerage institutions, and the brokerage channel has surpassed bancassurance to become its largest premium source. More small and medium-sized insurers will increase cooperation with brokerage platforms going forward. Platform operators can carry out targeted business development to expand their client base.

3. Risk mitigation: When partnering with life insurance institutions, platforms need to review the partner's solvency and operating compliance in advance, and prioritize cooperation with well-capitalized, operationally stable institutions. At the same time, they need to pay attention to surrender risk of co-sold products, prepare risk contingency plans in advance, and avoid damage to the platform's reputation.

This article provides a vivid case study for research on the development of small and medium-sized institutions in the life insurance industry, with the following key research insights:

1. New industry trends: The life insurance industry is seeing a clear divergence trend, and small and medium-sized institutions face significant operating pressure. Capital replenishment has become the core demand for these institutions to maintain compliant operations. Currently, most small and medium-sized life insurers rely solely on capital injections from existing shareholders, as external investors have limited willingness to enter the space, leaving capital replenishment channels very narrow.

2. New industry issues: This case breaks the traditional industry rule of "seven years of losses before turning profitable". Some small and medium-sized life insurers continue to face sustained losses and falling premium revenue more than a decade after establishment, while also grappling with the overlapping challenges of high surrender rates, poor-quality investment assets, and incomplete channel development.

3. Research implications: Regulators can introduce more supportive policies to meet the capital replenishment demand of small and medium-sized life insurers, and encourage entry of diversified capital. At the industry level, stakeholders need to guide small and medium-sized institutions to optimize business structure and build core independent profitability, to avoid long-term reliance on shareholder capital injections. From a business model perspective, building a differentiated channel strategy leveraging existing shareholder resources is currently a viable transformation direction for small and medium-sized life insurers.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

近日,中华联合人寿保险股份有限公司(以下简称:中华人寿)又有一笔3亿规模增资落地,引发业界关注。

7月3日,中华人寿公告称,公司于2026年6月收到监管批复,同意公司注册资本变更为44亿元。此次增资,是中华人寿两年多来的第三次增资。

作为国内唯一以“中华”冠名的国有控股寿险企业,中华人寿依托股东资源,通过股权增资、发行资本补充债券等多元渠道持续补充资本金,有效守住监管合规底线,为业务持续运营提供了重要支撑。

但从经营基本面来看,成立十余年来,该寿险公司尚未走出持续亏损态势,保费规模连续三年回落。持续的资本补充虽为公司赢得宝贵的调整窗口期,但若业务结构、盈利水平无法实现实质性改善,资本持续消耗的局面难以得到根治。

未来,中华人寿能否依托资本加持推进深层次经营改革,构建具备自我造血能力的发展模式,成为业界持续关注的一大看点。

1

3亿增资落地,

多渠道“补血”

成立于2015年的中华人寿,已走过了发展的第11个年头。

该寿险公司是一家全国性国有控股股份制人寿保险公司,总部设在北京。截至2025年末,公司资产总额419.24亿元。中华人寿已在新疆、北京、四川、河北、天津五个省级行政区开设10家分支机构。

中华人寿最大股东也是其发起人之一——中华联合保险集团,前身为新疆生产建设兵团农牧业生产保险公司,始创于1986年7月。2002年,经国务院批复同意,冠名“中华”,是全国唯一一家以“中华”冠名的国有控股保险集团。

另一发起人中华财险为中华联合保险集团旗下财险公司,截至2026年一季度末,中华联合保险集团在中华财险的持股比例为87.93%。业务经营范围涵盖非寿险业务的各个领域,目前公司经营的保险产品超万个,农险业务规模更是稳居全国前茅。

近日,中华人寿又迎来一笔来自股东方的3亿元的增资。

7月3日,中华人寿公告称,公司于2026年6月收到《国家金融监督管理总局北京监管局关于中华联合人寿保险股份有限公司变更注册资本的批复》,同意公司注册资本变更为44亿元,公司已依法办理营业执照变更工作。

需要注意的是,此次增资距离上次还不到一年时间。

近年来,中华人寿持续推进资本补充工作,多轮股权增资相继落地。

2024年5月,中华人寿顺利获批3亿元增资,新增资金全部用于充实核心资本金,短期缓解持续经营带来的资本消耗。

时隔一年,2025年6月又落地大额增资计划,本次增资规模达12亿元,也是近年来单次增资体量最高的一轮股权补充。

「子弹财经」注意到,历次股权增资出资主体固定,全部由两大股东中华联合保险集团、中华财险按照8:2比例内部出资,无外部资本入场。

除增资之外,中华人寿还通过发债方式进行资本补充。

2026年3月25日在银行间市场公开发行了规模为5.7亿元的“中华联合人寿保险股份有限公司2026年资本补充债券”。

本期债券发行规模为5.7亿元,10年期固定利率债券,在第5年末附有条件的发行人赎回权,由中华联合保险集团提供全额无条件不可撤销的连带责任保证担保。

股东持续增资与发债虽能够快速补充资本金、保障公司满足监管合规要求。但外部资金注入能起到短期缓冲作用,却难以从根本上扭转资本持续消耗的态势。

2

保费盈利双承压,

一季度再亏0.45亿

从业绩来看,中华人寿经营基本面持续走弱,偿付能力长期紧贴监管红线。

2026年一季度偿付能力报告显示,截至报告期末,公司综合偿付能力充足率122.85%,较上季度下降1.78%,核心偿付能力充足率85.24%,较上季度下降7.60%。风险综合评级为B类,且中华人寿预测下季度两项指标将继续下降至120.74%、84.65%。

按照保险监管要求,综合偿付能力100%、核心偿付能力50%以及风险综合评级B类,是偿付能力达标的三个底线要求。根据2026年5月国家金融监督管理总局披露的信息,2026年一季度末人身险行业综合和核心偿付能力充足率均值分别为170.7%和118.1%。

以此标准衡量,中华人寿综合、核心偿付能力充足率均明显低于人身险行业平均水平,仅满足监管达标底线,已逼近监管红线。当前公司仍面临较大的资本补充压力,需对偿付能力情况保持持续关注。

寿险行业素有“七亏八盈”的一说,即新设寿险公司通常前7年亏损、第8年左右逐步实现盈利,这一规律源自寿险业务前期的高额固定投入,利润释放存在显著滞后性。

但中华人寿对应行业周期走完了“七亏”阶段,却未能如期迎来“八盈”拐点。

Wind数据显示,中华人寿仅在成立之初的2016年实现0.05亿元的短暂盈利,此后便渐入持续亏损状况。

2023年中华人寿亏损额扩大至6.23亿元,2024年、2025年亏损额度回落至4.94亿元、2.83亿元。自成立以来,累计亏损规模超过21亿元。

保费方面,2016年至2021年,中华人寿保费一路上涨,从1.25亿元增长至51.64亿元。2022年保费达到65.14亿元的历史峰值。

但自此后,中华人寿保费连续三年走低。

Wind数据显示,2023年至2025年,中华人寿保费收入分别为57.39亿元、52.51亿元和45.62亿元。2023年,其保费同比下滑11.90%;2024年降幅小幅收窄至8.50%;2025年下滑压力再度加剧,同比下降13.12%。

中诚信国际在今年6月的评级报告中指出,受制于偿付能力充足率的约束,2025年中华人寿承保规模持续下降,年内规模保费收入与保险业务收入同比分别下降11.62%和13.12%。

2026年第一季度,中华人寿实现保险业务收入16.64亿元,同比下降17.17%;净利润为-0.45亿元,较上年同期由盈转亏,盈利压力持续加大。而上年同期净利润0.25亿元的盈利来自当期投资净收益的阶段性释放,并非承保端盈利改善。

3

渠道多元建设待完善,

投资资产质量需关注

尽管保费收入连降三年,但中华人寿营业收入持续上涨。

「子弹财经」注意到,这主要由于投资净收益的增长对于保费下滑形成有效抵补。Wind数据显示,近两年投资净收益分别为9.39亿元、12.16亿元,同比增长111.96%、29.50%。

但营业支出方面,中华人寿退保金自2023年大幅上涨。

2023年至2025年分别为11.44亿元、9.18亿元及11.29亿元,2023年同比增长高达161.19%,2024年出现短暂回落,2025年再度增长22.98%。

中诚信国际评级报告显示,2025年中华人寿迎来部分终身寿险产品退保高峰,导致当期退保支出同比增长。

中华人寿2025年四季度偿付能力显示,报告期内退保金额和综合退保率居前三位的产品分别为:中华福多多终身寿险、中华尊终身寿险及中华福满盈年金保险。

其中,两款为终身寿险产品,中华尊终身寿险累计退保金额最高达到3.96亿元、累计退保率最高达到8.40%。其余两款产品,中华福多多终身寿险、中华福满盈年金保险累计退保金额分别为2.66亿元、2.76亿元,业务渠道均为银保渠道。

长期以来,中华人寿的银保渠道为其核心业务渠道。

截至2025年末,中华人寿已与11家银行建立合作关系,覆盖工行、农行、中行、建行四家国有大行,民生、招行、北京银行,以及大连银行、昆仑银行、乌鲁木齐银行、河北银行四家地方性银行。

随着渠道多元化建设,银保渠道的规模保费贡献度持续下降。

近年来规模保费与收入占比连续三年下滑,从2023年第一大渠道52.01%下滑至2025年40.17%。

中介及创新渠道保费贡献度实现较快提升,2025年超越银保渠道成为公司第一大渠道。当前,中华人寿与明亚、大童等经纪公司和代理机构建立业务合作关系,主要集中于终身寿险销售。截至2025年末,合作总分中介代理公司合计84家。

个险渠道起步较晚、发展尚不成熟,销售人力呈现下降趋势;多元渠道仍处于培育阶段,两个渠道虽然近年保费收入占比有所增长,但贡献有限。

此外,「子弹财经」注意到评级报告还指出,信用风险持续暴露背景下,需关注中华人寿投资资产质量变化情况,并同步加强风险投资项目处置力度。

近年来,中华人寿投资资产规模稳步增长。

为增厚收益,该公司2025年加大对权益类资产中科创板块的布局,规模与占比显著抬升。除少部分自营股权投资外,中华人寿其余均委托中华联合保险集团资产管理中心进行管理。截至2025年末,公司投资资产较上年末增长16.46%。

但资产质量方面,中华人寿部分投资资产出现逾期或违约风险。

中诚信国际评级报告显示,截至2025年末,中华人寿持有的1笔公司债及7笔信托计划出现违约或逾期,涉及账面成本5.76亿元,减值后的账面价值为4.52亿元,项目底层资产主要涉及房地产与建筑行业。

2025年末,中华人寿针对上述出现逾期或违约风险的项目已计提减值1.25亿元,减值计提比例约为21.64%,减值计提比例较上年末有所上升。

中诚信国际在评级报告中指出,考虑到宏观经济仍处复苏态势、房地产行业受政策影响较大以及部分区域信用风险持续暴露的影响,公司信用债和非标资产投资的相关风险仍需保持密切关注。

目前相关资产风险处置进展如何?后续对非标、地产相关投资将采取怎样的风控策略?「子弹财经」就此致函中华人寿方面,截至发稿前未获回复。

整体来看,当前中华人寿正处于转型调整的关键阶段。

股东多轮增资、发债补血,有效夯实了公司资本实力,保障了公司正常经营与合规运营,投资端的亮眼表现也有效对冲了保费下滑压力、持续收窄亏损,但其长期积累的净利亏损、退保支出高增、资产信用风险待出清等经营问题尚待化解。

未来,中华人寿将如何持续依托股东资源优势,加快渠道多元化落地、严控投资风险,实现稳健高质量发展?对此,「子弹财经」将持续关注。

注:文/邢莉,文章来源:子弹财经(公众号ID:zidancaijing),本文为作者独立观点,不代表亿邦动力立场。

文章来源:子弹财经

广告
微信
朋友圈

FAQ回顾

中华人寿是一家什么性质的保险公司?

中华人寿成立于2015年,是国内唯一以“中华”冠名的全国性国有控股股份制人寿保险公司,总部设在北京,最大股东为中华联合保险集团,截至2025年末资产总额419.24亿元,已在5个省级行政区开设10家分支机构。

中华人寿近年保费收入表现怎么样?

中华人寿2022年保费收入达到65.14亿元的历史峰值,此后连续三年下滑,2023年至2025年保费收入分别为57.39亿元、52.51亿元、45.62亿元,2026年一季度保险业务收入16.64亿元,同比下降17.17%。

中华人寿当前偿付能力处于什么水平?

截至2026年一季度末,中华人寿综合偿付能力充足率为122.85%,核心偿付能力充足率为85.24%,风险综合评级为B类,仅满足监管达标底线,远低于人身险行业170.7%、118.1%的平均水平,已逼近监管红线。

中华人寿投资端存在哪些风险?

截至2025年末,中华人寿持有的1笔公司债及7笔信托计划出现违约或逾期,涉及账面成本5.76亿元,底层资产主要涉及房地产与建筑行业,已计提减值1.25亿元,信用债和非标资产投资相关风险仍需密切关注。

这么好看,分享一下?

朋友圈 分享

APP内打开

赞 +1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0